| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8964510 | Clinical Oncology | 2018 | 8 Pages |
Abstract
Dose-escalated radiotherapy was associated with promising rates of in-field local control, with the exception of cT4 tumours. Distant failure remains a significant competing risk. Our data supports the need for current trials re-examining the role of dose escalation in the modern era.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
R. Effeney, T. Shaw, B.H. Burmeister, E. Burmeister, J. Harvey, G.T. Mai, J. Thomas, A.P. Barbour, B.M. Smithers, D.I. Pryor,